|BC-based KeyStone Financial stated a “Buy” recommendation on Nuvo, and stated, “[w]e are initiating coverage on the stock with the recommendation of buying half of a full position (BUY HALF) at current prices with the intention to fll the other half.|
|A drug company is being accused of taking advantage of vulnerable people after marketing pain relief medications with identical ingredients as different products - and charging extra for one of them. Voltaren Emulgel is marketed as a pain reliever for.|
|The decline has pulled the company's trailing and forward P/E ratio under 7, which is a dirt-cheap valuation. Why do the. An earlier-than-expected launch of a generic version of Endo's Voltaren Gel, which threatens more than $200 million in annual.|
|The company is in talks with regulators in the UK and the US to bring the product to the market.. Futura Medical, which floated on the Aim market in 2001, also has other products in the pipeline, including pain relief gels using ibuprofen and.|
|Voltaren Gel, a topical treatment for joint pain, faces a generic rival. Endo's generic drugs have experienced price erosion, partially caused by consolidation among generic-drug makers. Meanwhile, other products have experienced regulatory delays.|
|Chief executive of Futura, James Barder, said: "We're delighted to sign this licensing agreement with Thornton & Ross for the UK rights to our topical diclofenac gel, TPR100.. The share price of Futura was down 0.53% at 56.70p at 1450 GMT on Tuesday.|
|Oral diclofenac tablets, which are used for short-term pain relief, will no longer be available as an over-the-counter (OTC) pharmacy medicine in the UK from 15 January 2015 because of a small risk of heart problems, the Medicines and Healthcare.|
|. widespread price-erosion across the generic-drug market -- a business that makes up over half of Endo's revenue at present -- the performance of Endo's pain management franchise (composed of Lidoderm, Opana ER, Percocet, and Voltaren Gel) during .|
|. often responsible for big price drops among pharma and biotech stocks. Endo International, for example, has had to deal with product liability issues at its women's health division, competition from a generic alternative to its Voltaren anti.|
|On the NHS, most prescriptions cost the patient nothing - simply because they belong to one of those groups, such as the over-60s, who qualify for free prescriptions. But the remainder - or, at least, those in England (other countries in the UK have.|
- Corbus Pharmaceuticals to Present Gene Expression Data from ...
- Fl registered cardiovascular invasive specialist licensing
- Fatal heart fears over use of common painkillers: Drugs including ...
- Pitfalls of technology licensing, urgent need for training among issues covered at panel discussion on Taiwan's ...
- Home care provider talks heart health, warns of negative drug interactions
- "I Have A Vaginal Disease That No One Talks About"
- Buy Viagra Online Uk Fast Delivery :: Save your Time and Money
- If you suffer from allergies, here's how you can find relief without a prescription
- Cetirizine Hydrochloride Market Analysis, Growth Forecast Analysis by Manufacturers, Regions, Type and Application ...
- 2012-16 Major League Baseball CBA Released to Public